Human tissues are composed of complex mixtures of different cell types and their biological analysis requires the procurement of pure samples of the cells of interest. Number of approaches have been used in attempts to overcome this difficulty. Laser capture microdissection (LCM) is anautomated sample preparation technology used to isolate and harvest the specific cells of interest from tissue, or organisms by direct microscopic visualization. The technique also called as laser microdissection (LMD), or laser assisted microdissection (LAM or LMD). This technology facilitates the formulation of homogenous isolates of clear cells through which DNA/RNA and various proteins can be achieved for further performingmass spectrophotometry, western blot analyses, polymerase chain reaction (PCR), and quantitative PCR. Certain benefits, such as contamination free and contact free technique, allows more efficient and accurate results, and preservance of cells with an original morphology are expected to provide good growth in the global market. Laser microdissection is now used in a large number of research fields, e.g. cancer research,neurology, forensics or climate research,and plant analysis. The method is for the time being also applied for manipulation of cell cultures or for microengraving of coverslips.A diversity of downstream applications of laser capture microdissection technique are exist includes DNA genotyping and loss-of-heterozygosity (LOH) analysis, RNA transcript profiling, proteomics discovery, cDNA library generation, and signal-pathway profiling.
Global laser capture microdissection market is segmented by product type, system type, application, and end users.By product, the global market further segmented intoinstruments, reagents and media, assay kits, consumables, and software and services.The system types segmented into infrared LCM, ultraviolet LCM,immunofluorescence LCM, and ultraviolet and infrared LCM. By considering application, LCM market segmented into diagnostics, research and development, and other applications.Whereas, by end users market might be segmented into academic and government research hospitals, institutes, pharmaceutical companies, CROs and biotechnology companies. Geographically, laser capture microdissection market can be categorized into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. By product type, instrument segment is expected to account largest share of the global LCM market during forecast period. However, consumables segment observed highest growth rate. Geographically, North America accounted largest share of the market due to availability of skilled personnel to handle LCM technology. However, Asian market is witnessing strongest growth during the forecast period due to expansion of LCM companies and R & D spending. Overall growth of the market is attributed due to strong trend in CROs and pharmaceutical companies. Hence, by end users pharmaceutical companies’ accounted largest share in global laser capture microdissection market 2014.
Increasing healthcare expenditure, growing R & D funding, and technical advantages are primary growth drivers of this market. The high-growth potential in emerging markets provide new growth opportunities and technological advancements provide new growth trends to players in the laser capture microdissection market. However,high manufacturing and maintenance cost of equipment and accessories, and lack of skilled personnel are major restraint of the Laser capture microdissection market.
Some of the major players in the laser capture microdissection market include Thermo Fisher Scientific, Inc. (U.S.), Molecular, Machines & Industries (Germany),Danaher Corporation (U.S.), Carl Zeiss AG (Germany), INDIVUMED GmbH (Germany), DeNova Sciences Pte. Ltd. (Singapore), Theranostics Health Inc. (U.S.), Ocimum Biosolutions LLC (U.S.), 3DHISTECH Ltd. (Hungary), and AvanSci Bio LLC (U.S.).
Over the past two decades, information technology has revolutionized every facet of the mankind. In current scenario, healthcare practices of all types and sizes, and information is both a benefit and a challenge for every provider. Awareness about the disease and treatment is saving lives, while lack of effectively managed data might place this information at risk. Although, several pilot and cohort studies has been undertaken by government organizations and institutions pertaining to effectiveness of a computerized patient healthcare information system. Despite such studies many hospitals/providers especially in emerging markets have not successfully introduced an electronic health record (EHR) with clinical data entry at the point of care which clearly illustrates latent gap and scope of market expansion in forthcoming years.
The global EHR market has been studied from three broad perspectives: by installation type, by end users, and by geography. The market by installation type is further assessed and estimated by web-based, client server-based and software as a services. Moreover, the market by end users segment is sub-categorized into hospitals, physician’s office, and ambulatory centers. Whereas, in terms of geographical analysis the report provide detailed illustration and market trends for five regions i.e. North America, Europe, Asia Pacific, Latin America and Rest of the World. The global electronic health record market was valued at US$ 18,932.1 Mn in 2014 and is projected to reach US$ 30,280.0 Mn by 2023, expanding at a CAGR of 5.4% during the forecast period.
The study depicted that the client server-based installation type accounted for lion’s share in the market enabling transmission of data from server to the client at a higher rate as compared to cloud-based EHR system, primarily due to the close proximity and direct connections which streamlines the overall health care process. Whereas, pertaining to market growth, software as service (SaaS) market is projected to poise the fastest growth rate driven by low cost, increased demand from small organizations and provisions to store data at an off-site vendor location.
In the end user segment, hospitals are among the most prominent buyers as around 59% of the hospitals across the globe have installed some form of EHR in 2013 compared to 34% in 2012. Majority of the hospitals have adopted client server-based EHR systems in order to improve the health care of the patients. However, several hospitals are expected to opt for cloud-based EHR systems during the forecast period from 2015 to 2023 due to continued advances in the area of cloud computing. As government and non-government organizations encourage physicians to adopt EHR systems is assessed to be one of the contributing factors driving the growth of the ambulatory centers segment. Additionally, the U.S. Federal Government allocated US$ 27 Bn with the intent to encourage EHR adoption across the nation as part of the Health Information Technology for Economic and Clinical Health (HITECH) Act, 2009.
Geographically, North America which is a cumulative market for the U.S. and Canada has major share in the market in 2014 primarily attributed by favorable government policies such as pay for value and rapid inclination towards installation of EHR platforms across care providers segment. According to the National Coordinator for Health Information Technology (ONC), adoption of EHR systems among non-federal acute care hospitals in the U.S. has increased more than five-fold since 2008. Moreover, 77% of primary care doctors and 73% of specialists are using electronic medical records to record patient encounters as of 2016. Factors responsible for market growth in the U.K. and Germany include rapidly increasing geriatric population, growing need for remote monitoring, increased pressure of health care cost containment, and increasing demand for improved patient care. Moreover, the Government of Italy under Italian Health Service is developing EHR systems for e-prescriptions and for the transfer of medical data.
Latin America market followed by Asia Pacific are evaluated to be the fastest emerging market in coming years due to consistent growth in health care infrastructures followed by growing awareness to centralized patient current and past data have successfully initiated the demand and installation process in these regions. The EHR market in China has attracted both local and international EHR service providers such as IBM, Dell, Cisco, Siemens, and Fujitsu, and regional suppliers such as Yonyou, DHC, Neusoft, B-Soft, Winning, Founder, and Jiangsu Zhongkang.
Key players profiled in the electronic health record market study encompasses Allscripts Healthcare Solutions, Inc., Athenahealth, Inc., Cerner Corporation, CPSI, Epic Systems, eClinicalWorks, GE Healthcare, Greenway Health, LLC, Medical Information Technology, Inc., McKesson Corporation, NextGen Healthcare and 4medica.
In a new report, titled “Plastic Surgery & Integumentary System Procedures Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” Transparency Market Research (TMR) provides a comprehensive overview of the growth trajectory exhibited by the global market for plastic surgery and integumentary system procedures. The report presents insights into the key factors impacting the market’s growth trajectory during the forecast period between 2013 and 2019. It also includes valuable insights from industry veterans.
In the last few years, plastic surgery has gained much prominence in the global market as a popular medical procedure to restore, correct, and alter skin or other body parts. Plastic surgery in most cases is performed as a cosmetic and reconstructive procedure. A reconstructive plastic surgery is performed for the correction of functional injuries and impairments resulting from congenital abnormalities, burns, and traumatic injuries. On the contrary, cosmetic surgeries involve invasive procedures such as eyelid surgery and breast augmentation, and non-invasive procedures such as botox, laser hair removal, chemical peels, and others. Cosmetic surgeries are in general performed to aesthetically improve a person’s appearance.
Request For Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1793
The integumentary system consists of skin and its appendages such as nails, hair, and exocrine glands, which provide the body protection against any kind of damage or abrasion caused by external factors. A healthcare practitioner recommends integumentary procedures in case of infections, rashes, athlete’s foot, sun burn, psoriasis, acne, rabies, herpes, rubella, and skin cancer.
Globally, the demand for plastic surgery and integumentary system procedures has substantially increased in recent years, encouraging market players to focus on strategies capitalizing on the prevailing lucrative opportunities. The report provides an executive-level blueprint of the global market for plastic surgery and integumentary system procedures. It includes results obtained from investment feasibility analysis to update both existing players in the market and new entrants about how profitable it will be to invest in the market during the forecast period.
For the purpose of the study, the report broadly classifies the market based on target organ during surgical procedures. This includes nose, breasts, eyelids, and subcutaneous and skin tissues. The most widely used techniques and procedures for performing surgeries on targeted organs include rhinoplasty, rhytidectomy, biopsy, mastectomy, breast reduction and augmentation, skin graft, removal of tumors, abdominoplasty, and excision and incision procedures.
Regionally, the report studies the dynamics of the market across four key regions: Asia Pacific, Europe, North America, and Rest of the World. Of these, North America accounts for the largest share in the global market for plastic surgery and integumentary system procedures. The region boasts being an early adopter of several advances in surgical procedures, which augments the demand for plastic surgeries from the region. Furthermore, the rising geriatric population and rapidly changing lifestyle preferences of people living in this region also boost the market for plastic surgery and integumentary system procedures in North America.
The automated breast ultrasound system is primarily designed to obtain ultrasound images with the help of a broadband transducer which is scanned over the whole breast to capture 3D ultrasound volume data. It provides 3D images and detects cancer in dense breast tissues. The market for automated breast ultrasound system has been segmented by application which includes hospitals and research labs and diagnostic laboratories among others. The automated breast ultrasound system enables quicker scan time, reduces the operator dependence. It also increases the reproducibility, consistency, reliability and sensitivity of each individual full breast ultrasound diagnosis. With the growing prevalence of breast cancer and increasing patient awareness towards the connection of breast density with breast cancer is fueling the demand for automated breast ultrasound system.
With the growing awareness towards the symptoms of breast cancer along with rising radiology market is some of the major driving factors for the market. Furthermore, growing extensive research and development for upgraded imaging techniques along with increasing government advocation towards the breast cancer awareness is also acting as drivers for the market. Furthermore high maintenance and manufacturing cost of magnetic resonance imaging (MRI), exposure to radiation and lack of expertise in this field is some of the restraining factors which may hinder the growth of this market. However, the benefits obtained from the automated breast ultrasound system such as 3D images and coronal view, less turnaround time along with assurance of improved diagnostic results are stimulating the market at the global level.
Download Sample PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8449
With the increasing technological advancement and growing application of automated breast ultrasound system in hospitals and research institutes and diagnostic laboratories are fueling the market globally. North America dominated the market for automated breast ultrasound system followed by Europe in 2014 and is expected to maintain its position over the forecast period 2015 to 2023. U.S. is the major market across North America. Furthermore, increasing awareness towards detecting breast cancer at the primary stage in order to avoid life risks associated with the diseases along with expenditure on research and development activities to upgrade technologies for better accurate results are driving the market across Asia Pacific. Japan, China, India among others contributes in the positive growth of this market across Asia Pacific. Growing number areas of hospitals and imaging diagnostic centers primarily for cancer patients are having a positive impact on the growing market for automated breast ultrasound system in Rest of the World (RoW).
Some of the major players operating in the automated breast ultrasound system market are Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S), SonoCine Inc. (U.S.), Hitachi, Ltd.(Japan) among others. Increasing strategic alliances between major companies for better market penetration is one of the major strategies adopted by key players. Furthermore, manufacturers in developing countries are investing in the healthcare and mammography sector in order to provide advance medical instruments which in turn are contributing in the positive growth of automated breast ultrasound system market globally.
A new market research report by Transparency Market Research, titled “Bio-Implants Market – Global Industry Analysis, Size, Share And Forecast 2012 – 2018,” provides an extensive assessment of the market for bio-implants and comprises facts, insights, historical data, and industry-validated and statistically supported market data. It also comprises projections utilizing an apt set of methodologies and assumptions. The study presents information and evaluation on the basis of geography and application. This study is a compilation of quantitative and qualitative assessment by industry participants and industry experts across the value chain. An in-depth evaluation of macro-economic indicators, parent market trends, and market attractiveness has been provided with the help of this research report.
The report states that the use of bio-implants enables faster treatment with negligible complications and this makes them preferable over the conventional forms of implants. As per this research study, the market for bio-implants is predicted to grow exponentially owing to the swiftly developing healthcare infrastructure in developing as well as developed regions. In addition, the rising occurrence of chronic health disorders, particularly in the geriatric population, along with the increasing disposable incomes of people, is predicted to boost the bio-implants market. On the other hand, factors such as soaring costs of treatment and reimbursement problems may inhibit the growth of the market in forthcoming years. In terms of type of implant, the market is segmented into autografts, allografts, and xenografts. On the basis of therapeutic area, the report segments the market into dental, orthopedic, ophthalmic, and others.
As per this study, on the basis of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America led the market in 2012 and was trailed by Asia Pacific and Europe. However, the market for bio-implants is expected to face a downturn in the region of North America owing to the rising austerity measures and taxation by the Federal government. In addition, within European countries, the ongoing euro crisis is also predicted to impede the growth of the market. The region of Asia Pacific is anticipated to experience swift growth in the coming years owing to rising foreign investments and government funding, as mentioned in this report.
According to this study, the chief players operating in the market for bio-implants are Biomet, Inc. (U.S.), Tornier N.V. (The Netherlands), Smith & Nephew (U.K.), Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic (U.S.), Synthes (U.S.), and others.